ClinConnect ClinConnect Logo
Search / Trial NCT04791748

Virtual Reality in Children with and Without Vestibular Deficits

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Mar 8, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Chronic Vestibular Deficit In Children Virtual Reality Protocol Multisensory Integration Hand Eye Coordination

ClinConnect Summary

This clinical trial is exploring the use of virtual reality (VR) to help children with and without vestibular deficits, which are conditions affecting balance and spatial awareness. The goal is to create a fun and engaging way to assess and improve how these children coordinate their movements, particularly their hand-eye coordination. By using VR technology, researchers hope to better understand how children process sensory information—like what they see and feel—in relation to their surroundings. This could lead to new and effective treatment methods for those with balance issues.

To participate in the study, children aged 7 to 17 years who have vestibular problems or are healthy volunteers may be eligible. Participants will be asked to engage with VR activities that are safe and enjoyable. However, children with certain eye or neurological conditions may not be included. This trial aims to establish a reliable and age-appropriate VR protocol that could ultimately benefit many young patients by enhancing their quality of life and developmental outcomes.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Minors aged 7 to 17 years (inclusive)
  • Volunteers adult
  • Information and consent of holders of parental authority of minors, minors and of adult subjects
  • Patients :
  • Presence of unilateral or bilateral chronic vestibular pathology
  • Minor patients followed in consultation at Necker Hospital in the Pediatric ENT department
  • Adult patients followed at adult vestibulometry services (Lariboisière and Pitié Salpêtrière Hospitals)
  • Controls:
  • No history of otological surgery and absence of vestibular pathology
  • Patients followed in consultation at Necker Hospital, siblings or adult parents
  • Exclusion Criteria:
  • Presence of an ophthalmological pathology (including refractive errors)
  • Presence of neurological pathology including epilepsy or any pathology that can alter mobility and interfere with the performance of tasks

About Assistance Publique Hôpitaux De Paris

Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.

Locations

Paris, , France

Patients applied

0 patients applied

Trial Officials

Françoise Denoyelle, MD, PhD

Principal Investigator

Assistance Publique - Hôpitaux de Paris

François SIMON, MD, PhD

Study Director

Assistance Publique - Hôpitaux de Paris

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials